tldrdaily.news logo
Tag

Drug Sales

All articles tagged with #drug sales

business5 months ago

Eli Lilly Boosts 2025 Outlook Amid Strong Weight-Loss Drug Sales

Eli Lilly raised its 2025 sales and earnings guidance driven by strong demand for its weight loss and diabetes drugs Mounjaro and Zepbound, with second-quarter earnings surpassing estimates. The company also released trial data for its obesity pill, forglipron, which showed promising weight loss results but fell short of expectations, causing shares to drop. Despite robust revenue growth, Eli Lilly faces potential U.S. import tariffs and political pressure to lower drug prices.

via CNBC|
#2025-guidance#business#drug-sales
health-medicine1 year ago

"Slow Start for 1st Drug in Slowing Alzheimer's Progression"

The first drug shown to slow Alzheimer’s disease, Leqembi, has had a slow start in the U.S. market, with lagging sales, delayed hospital adoption, and insurance coverage rejections. While offering hope for patients, the drug's limited impact and potential side effects have led to cautious uptake. Challenges include setting up systems for drug delivery, understanding coverage, and identifying eligible patients. Despite these hurdles, the drug's maker, Eisai, remains optimistic about its potential and is working on an injectable version and seeking approval for an easier-to-use form.

via AL.com|
#alzheimers#drug-sales#health-medicine
technologycrime1 year ago

"US Prosecutors Investigate Meta's Role in Drug Sales and Self-Harm Content"

US prosecutors are investigating whether Meta's social-media platforms are facilitating and profiting from illegal drug sales, having sent subpoenas seeking records on drug content and sales. Meta claims to proactively remove illicit drug content and cooperate with law enforcement, while also joining the Alliance to Prevent Drug Harms. The company's president of global affairs announced this after the US and the UN Office on Drugs and Crime initiated a collaborative effort with Meta and others to disrupt synthetic drug activity online.

via The Verge|
#drug-sales#illegal-activity#law-enforcement
technology1 year ago

"Meta Faces U.S. Probe Over Alleged Drug Sales on Platforms: WSJ"

Meta, the parent company of Facebook and Instagram, is under investigation by federal authorities for allegedly facilitating or profiting from drug sales on its platforms. The investigation in Virginia has prompted Meta to provide company records regarding drug-related content and illicit drug sales. The company claims to actively combat the sale and distribution of illicit drugs and collaborates with other technology companies and law enforcement to prevent such activities. The State Department has also announced a collaborative campaign with social media companies, including Meta, to combat online drug trafficking.

via Fox Business|
#drug-sales#facebook#instagram
technologycrime1 year ago

"U.S. Probes Meta for Drug Sales and Self-Harm Content Issues"

U.S. prosecutors in Virginia are investigating whether Meta's social media platforms facilitated and profited from illegal drug sales, with the FDA assisting in the probe. Subpoenas have been sent and records related to drug content on Meta's platforms are being requested. Meta stated that the sale of illicit drugs goes against their policies and that they actively cooperate with law enforcement to combat such activities. The investigation is ongoing, and Meta, the FDA, and the Virginia Attorney General's office have not yet commented.

via CNBC|
#drug-sales#facebook#investigation
business2 years ago

Pfizer's Q1 earnings exceed expectations with COVID products leading the way.

Pfizer reported better-than-expected revenue and profit for Q1 2021, driven by steady demand for its COVID-19 products, including its vaccine and antiviral pill. The company reaffirmed its annual earnings forecast and expects newer drugs to contribute to growth later this year. Pfizer is investing in research and potential blockbuster assets to mitigate an anticipated $17 billion hit to revenue by 2030 from patent expirations for top drugs and a decline in demand for its COVID-19 products. The drugmaker expects annual profit of $3.25 to $3.45 per share and COVID-19 product sales of about $21.5 billion.

via Yahoo Finance|
#business#covid-19#drug-sales